Form 4: Progyny Director Acquires 44,000 Stock Options

Progyny director Debra L. Morris acquired 44,000 stock options at an exercise price of $20.62 on January 16, 2025.

Summary

• Debra L. Morris, a director at Progyny, Inc., acquired 44,000 stock options on January 16, 2025.
• The exercise price for these options is $20.62 per share.
• The options vest 25% on the first anniversary of the grant date, with the remainder vesting in equal quarterly installments over the following three years, contingent on continued service.
• The options expire on January 15, 2035.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of a stock option grant to a director. It is neither particularly positive nor negative, but it does indicate that a director has a vested interest in the company's performance.

Positives

• The acquisition of stock options by a director can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation and incentive programs.
• The vesting schedule of 25% after one year and the remainder quarterly is a typical vesting structure.
• The 10-year expiration period is also a standard term for stock options.

Stakeholder Impact

• The stock option grant aligns the director's interests with those of shareholders, as the value of the options is tied to the company's stock price.

Key Dates

Keywords

stock options, Progyny, director, insider trading, equity, vesting